Todd Daniel Barton - Faculty Biosketch

Todd Daniel Barton, M.D.

Professor of Clinical Medicine (Infectious Diseases)

Attending Physician, Penn Presbyterian Medical Center

Attending Physician, Hospital of the University of Pennsylvania

3 5f

Department: Medicine

4 1 b

46 Contact information
56

3rd floor, Silverstein Building, Suite E
50 Hospital of the University Pennsylvania
Philadelphia,, PA 19104-4283

2c Office: 2158735119
30

4 3 3 3 2 4 b 1f

13 Education:
21 7 BA 20 (English / Chemistry) c
2b Swarthmore College, 1992.
21 7 MD c
43 University of Rochester School of Medicine, 1997.
c

3 3 21

1f Post-Graduate Training
24 5c Intern in Medicine, Hospital of the University of Pennsylvania, 1997-1998.
24 5e Resident in Medicine, Hospital of the University of Pennsylvania, 1998-2000.
24 6b Chief Resident, Internal Medicine, Hospital of the University of Pennsylvania, 2000-2001.
24 71 Fellow, Division of Infectious Diseases, Hospital of the University of Pennsylvania, 2001-2003.
c

3 25

17 Certifications
28 5b Diplomat in Internal Medicine, American Board of Internal Medicine, 2020.
28 5d Diplomat in Infectious Diseases, American Board of Internal Medicine, 2023.
c

3 8b Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

Description of Clinical Expertise

2d clinical infectious diseases
21 graduate medical education
1a 29

Selected Publications

81 Volkman KM, Barton TD, Colby K, Goldberger ZD, White AA: Stranger than fiction 40 J Hospital Med 10(5): 314-17, May 2015.

c3 Longworth SA, Blumberg EA, Barton TD, Vinnard C: Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis 45 Clin Microbiol Infect 21(1): 43-7, Jan 2015.

b6 Longworth SA, Vinnard C, Lee I, Sims KD, Barton TD, Blumberg EA: Risk factors for nontuberculous mycobacterial infections in solid 33 organ transplant recipients: a case control study 43 Transpl Infect Dis 16(1): 76-83, Feb 2014.

120 Blyth D, Lee I, Sims KD, Gasink LB, Barton TD: Risk factors and clinical outcomes of cytomegalovirus disease occurring more than one year post solid organ transplantation. Transpl Infect Dis 14(2): 149-55, Apr 2012.

17a Mascitti KB, Gerber JS, Zaoutis TE, Barton TD, Lautenbach E: Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers. Am J Infect Control 38(4): 324-8, May 2010.

d9 Vinnard C, Barton TD, Jerud E, Blumberg EA: A report of HHV-6 associated encephalitis in a solid organ transplant recipient and a review of previously published cases 40 Liver Transpl 15(10): 1242-6, Oct 2009.

159 Shiley KT, Gasink LB, Barton TD, Pfeiffenberger P, Olthoff KM, Blumberg EA: Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis. Liver Transpl 15(8): 963-7, Aug 2009.

d5 Linkin DR, Fishman NO, Landis JR, Barton TD, Gluckman S, Kostman J, Metlay JP: Effect of communication errors during calls to an antimicrobial stewardship program 51 Infect Control Hosp Epidemiol 28(12): 1374-81, Dec 2007

14b Barton TD, Blumberg EA, Doyle A, Ahya VN, Ferrenberg JM, Brozena SC, Limaye AP: A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction. Transpl Infect Dis 8(2): 102-7, Jun 2006.

fb Sims KD, Barton TD: Group B streptococcal toxic shock syndrome in an asplenic patient: case report and literature review. Eur J Clin Microbiol Infect Dis 25(3): 208-10, Mar 2006.

2c

7 1d

2c back to top
26 Last updated: 08/18/2025
34 The Trustees of the University of Pennsylvania c